Combined ADAMTS10 and ADAMTS17 inactivation exacerbates bone shortening and skin phenotypes
Life Science Alliance · 2025
DOI: 10.26508/lsa.202503232 ↗Kurz gefasst
Fachartikel in der Zeitschrift Life Science Alliance, 2025. Verfasst von Nandaraj Taye und 10 weiteren Autor:innen. Beteiligte Einrichtung: Orthopedic Research Laboratories, Leni and Peter W. May Department of Orthopedics, Icahn School of Medicine at Mount Sinai, New York, NY, USA. Hauptthemen laut MEDLINE: ADAMTS Proteins, Weill-Marchesani Syndrome. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 68 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAMS NIH HHS, HHS | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases.
Abstract (Originalsprache)
Weill–Marchesani syndrome (WMS) is characterized by severe short stature, joint contractures, tight skin, heart valve and eye anomalies. WMS is caused by biallelic mutations in ADAMTS10 , ADAMTS17 , or LTBP2 , or mono-allelic mutations in FBN1 . Because bone growth is driven by chondrocyte proliferation and hypertrophy in the growth plates, the genetics of WMS suggests that the affected extracellular matrix (ECM) proteins contribute to chondrocyte and growth plate function. Here, we show that Adamts10 ; Adamts17 double knockout (DKO) mice have significant postnatal lethality and exacerbated bone shortening, which correlated with a narrower hypertrophic zone in their growth plates. Potential ADAMTS17 substrates identified by N-terminomics and yeast-2-hybrid screening revealed the ECM proteins fibronectin ( FN1 ) and collagen VI ( COL6A2 ). In primary ADAMTS10- and ADAMTS17-deficient skin fibroblasts, fibronectin deposition was impaired concomitant with aberrant intracellular accumulation of fibrillin-1. These findings support a role for ADAMTS17 in ECM protein secretion and assembly. Mechanistically, ADAMTS17 appears to be a critical regulator of ECM protein secretion or pericellular matrix assembly, whereas ADAMTS10 likely modulates ECM formation at later stages.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Orthopedic Research Laboratories, Leni and Peter W. May Department of Orthopedics, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
- Department of Biomedical Engineering, Cleveland Clinic Lerner Research Institute, Cleveland, OH, USA.
- Department of Orthopaedic Surgery, Cleveland Clinic Orthopaedic and Rheumatologic Institute, Cleveland, OH, USA.
- Proteomics and Metabolomics Core, Cleveland Clinic Lerner Research Institute, Cleveland, OH, USA.
- Human Evolutionary Biology, Harvard University, Cambridge, MA, USA.
- Broad Institute of MIT and Harvard, Cambridge, MA, USA.
ORCID-Profile: Stylianos Z Karoulias, Daniel Martin, Alexander S Okamoto, Dirk Hubmacher
Förderung
- NIAMS NIH HHS
- HHS | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases
Zitieren
APA
Taye, N., Karoulias, S. Z., Balic, Z., Wang, L. W., Willard, B. B., Martin, D., Richard, D., Okamoto, A. S., Capellini, T. D., Apte, S. S., & Hubmacher, D. (2025). Combined ADAMTS10 and ADAMTS17 inactivation exacerbates bone shortening and skin phenotypes. Life Science Alliance. https://doi.org/10.26508/lsa.202503232
Vancouver
Taye N, Karoulias SZ, Balic Z, Wang LW, Willard BB, Martin D, et al. Combined ADAMTS10 and ADAMTS17 inactivation exacerbates bone shortening and skin phenotypes. Life Science Alliance. 2025. doi:10.26508/lsa.202503232
BibTeX
@article{Taye2025,
author = {Taye, Nandaraj and Karoulias, Stylianos Z and Balic, Zerina and Wang, Lauren W and Willard, Belinda B and Martin, Daniel and Richard, Daniel and Okamoto, Alexander S and Capellini, Terence D and Apte, Suneel S and Hubmacher, Dirk},
title = {Combined ADAMTS10 and ADAMTS17 inactivation exacerbates bone shortening and skin phenotypes},
journal = {Life Science Alliance},
year = {2025},
doi = {10.26508/lsa.202503232}
}
EUVIMED